Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients

Copyright © 2020 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 219(2020) vom: 15. Okt., Seite 108570
1. Verfasser: Fang, Zhong (VerfasserIn)
Weitere Verfasser: Yu, Xiaoyu, Tong, Shuangmei, Lu, Chuan, Huang, Yuxian, Chen, Liang, Yuan, Zhenghong, Zhang, Yi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Biomarker Chronic hepatitis B Extracellular signal regulated kinase-1/2 HBV-specific CD8(+) T cells IFNα Hepatitis B Antibodies Interferon-alpha STAT3 Transcription Factor mehr... STAT3 protein, human MAPK1 protein, human EC 2.7.11.24 MAPK3 protein, human Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3